Cancer Drug Development Forum ASBL
3.1 FTECancer Drug Development Forum reported total assets of €1.67m at the end of the 2025 financial year (annual accounts filed with the NBB on 28 May 2026), with 3.1 full-time equivalents.
By total assets for 2025, Cancer Drug Development Forum ranks in the top half of the 847 companies in its sector (NACE 9499) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Cancer Drug Development Forum shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity 0 % Total assets +24 % Headcount (avg FTE) +24 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Cancer Drug Development Forum's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 May 2026
- Year ended 31 Dec 2024filed on 28 May 2025
- Year ended 31 Dec 2023filed on 04 Dec 2024
Cancer Drug Development Forum's financial analysis
- Solvency48.6%sector median: 44.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Cancer Drug Development Forum
14 active director(s) in the register.
and 8 more
Cancer Drug Development Forum's shareholders and holdings →Cancer Drug Development Forum's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0738.523.752
- VAT number
- BE0738523752
- Peppol
- Registered · 0208:0738523752 · as of 10 Nov 2026
- Legal form
- ASBL
- Incorporated
- 28 Nov 2019
- Registered office
- 1200 Woluwe-Saint-Lambert
- Size
- Micro · 3.1 FTE
- Latest accounts
- 2025 · filed on 28 May 2026
- Activity
- Activities of illness prevention and health promotion associations (NACE 94993)
Cancer Drug Development Forum (ASBL) has been based in Woluwe-Saint-Lambert since 2019, active in: activities of illness prevention and health promotion associations. For 2025, it reports a net profit of 9,186 € and equity of 809,743 €; its revenue is not published. With 3.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 48.6%, above the median of its sector (44.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Cancer Drug Development Forum
Companies in the same business, of comparable size and area, outside its group.
- Alzheimer Belgique Activities of other membership organisations n.e.c. Etterbeek · balance sheet €2.62m
- Association Europeenne des Ligues contre le Cancer Activities of other membership organisations n.e.c. Schaerbeek · balance sheet 906,441 €
- Digestive Cancers Europe Activities of other membership organisations n.e.c. Brussels · balance sheet €2.26m
- Forum des Patients Europeens Organisation of conventions and trade shows Brussels · balance sheet €1.78m
- I.Care Activities of other membership organisations n.e.c. Schaerbeek · balance sheet 801,611 €
- CathoBel Publishing of books Wavre · balance sheet €1.70m
- Ons Erfdeel Publishing of journals and periodicals Ghent · balance sheet 987,493 €
- European Regional and Local Health Authorities Activities of other membership organisations n.e.c. Etterbeek · balance sheet 547,258 €
Frequently asked questions about Cancer Drug Development Forum
What is the revenue of Cancer Drug Development Forum?
Cancer Drug Development Forum files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Cancer Drug Development Forum?
In Belgium, the VAT number is the company number prefixed with BE: BE0738523752 for Cancer Drug Development Forum, if the company is VAT-registered. Its company number (CBE) is 0738.523.752.
Where is the registered office of Cancer Drug Development Forum?
According to the CBE register, the registered office of Cancer Drug Development Forum is in 1200 Woluwe-Saint-Lambert.
What is the equity of Cancer Drug Development Forum?
At the close of the 2025 financial year, the equity of Cancer Drug Development Forum amounts to 809,743 €, a solvency of 48.6% of total assets.
How many people work at Cancer Drug Development Forum?
3.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Cancer Drug Development Forum?
The register lists 14 active mandates at Cancer Drug Development Forum. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Cancer Drug Development Forum within its sector?
By total assets for 2025, Cancer Drug Development Forum ranks in the top half of the 847 companies in its sector (NACE 9499) in Belgium that filed accounts for that financial year.
The full file of Cancer Drug Development Forum
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →